Adel Shahnam

Oncology

1275 York Ave
New York, NY 10065

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

BRIGHTLINE-1: When a Negative Trial Reveals Two Active Therapies.

BRIGHTLINE-1: When a Negative Trial Reveals Two Active Therapies.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 06, 2026

Natural history and treatment outcomes in aggressive angiomyxoma: A single institution experience.

Natural history and treatment outcomes in aggressive angiomyxoma: A single institution experience.

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 27, 2026

Perspectives of people affected by cancer toward generative AI in oncology: A scoping review of applications, evidence gaps, and future priorities.

Perspectives of people affected by cancer toward generative AI in oncology: A scoping review of applications, evidence gaps, and future priorities.

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 02, 2026

Concomitant Medication Effects on Immunotherapy Outcomes in Sarcoma: A Pooled Post Hoc Analysis of Seven Phase II Trials.

Concomitant Medication Effects on Immunotherapy Outcomes in Sarcoma: A Pooled Post Hoc Analysis of Seven Phase II Trials.

Journal: Cancer medicine

Published: April 08, 2026

Applying Radiomics to Predict Outcomes in Patients with High-Grade Retroperitoneal Sarcoma Treated with Preoperative Radiotherapy.

Applying Radiomics to Predict Outcomes in Patients with High-Grade Retroperitoneal Sarcoma Treated with Preoperative Radiotherapy.

Journal: Journal of imaging

Published: October 08, 2025

Clinical Utility of an RNA-based Gene Fusion Assay in Sarcoma for Diagnosis and Management: Experience in an Australian Laboratory.

Clinical Utility of an RNA-based Gene Fusion Assay in Sarcoma for Diagnosis and Management: Experience in an Australian Laboratory.

Journal: Molecular diagnosis & therapy

Published: July 28, 2025

Heterogeneous treatment effect of immune checkpoint inhibitors by pretreatment prognosis in randomized controlled trials.

Heterogeneous treatment effect of immune checkpoint inhibitors by pretreatment prognosis in randomized controlled trials.

Journal: JNCI cancer spectrum

Published: June 29, 2025

Application of Generative Artificial Intelligence for Physician and Patient Oncology Letters-AI-OncLetters.

Application of Generative Artificial Intelligence for Physician and Patient Oncology Letters-AI-OncLetters.

Journal: JCO clinical cancer informatics

Published: May 02, 2025

Impact of age and comorbidity on safety outcomes in phase 1 trial participants for metastatic solid malignancies.

Impact of age and comorbidity on safety outcomes in phase 1 trial participants for metastatic solid malignancies.

Journal: Journal of geriatric oncology

Published: April 07, 2025

Real-World outcomes of Non-Small cell lung cancer patients harbouring KRAS G12C and KRAS G12D mutations.

Real-World outcomes of Non-Small cell lung cancer patients harbouring KRAS G12C and KRAS G12D mutations.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: January 30, 2025

Real-World Trends and Outcomes for Localized High-Grade Soft Tissue Sarcoma: Insights from a Sarcoma Unit in Australia.

Real-World Trends and Outcomes for Localized High-Grade Soft Tissue Sarcoma: Insights from a Sarcoma Unit in Australia.

Journal: Asia-Pacific journal of clinical oncology

Published: January 23, 2025

Patient-reported outcome thresholds and their associations with survival, adverse events, and quality of life in a pooled analysis of breast cancer trials.

Patient-reported outcome thresholds and their associations with survival, adverse events, and quality of life in a pooled analysis of breast cancer trials.

Journal: International journal of cancer

Published: January 07, 2025

Showing 1-12 of 33

Last Updated: 09/26/2026